U.S. President Donald Trump's administration cancelled a major contract to supply emergency kits for rape survivors in Congo ...

Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare law that ...

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Donald Trump's cuts to HIV/AIDS programmes will further derail an already faltering plan to end the disease as a public ...

June 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in ...

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks ...

June 10 (Reuters) - The U.S. Food and Drug Administration has paused Gilead Sciences' , opens new tab trials testing a combination of two of its experimental HIV treatments due to low levels of a ...

Donald Trump's cuts to HIV/AIDS programmes will further derail an already faltering plan to end the disease as a public health threat by 2030, UNAIDS Executive Director Winnie Byanyima said on Friday.